Tag archive for ‘Can-Fite Biopharma (NYSE MKT: CANF) (TASE: CFBI)’

Cipher Pharmaceuticals acquires Canadian rights from Israeli Can-Fite for psoriasis, rheumatoid arthritis treatment

  Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Israeli Can-Fite Biopharma (NYSE MKT: CANF) (TASE: More...

Wordpress site Developed by Fixing WordPress Problems